\
&
Contact us
\
&
Contact us
Published on | 3 months ago
ProgrammesThe Digital Skills and Jobs Platform launches the 2026 edition of the European Digital Skills Awards. The call for submissions is now open, inviting eligible initiatives to present their proposals, and offering the chance to be recognised for their contribution to shaping Europe's digital future.
The European Commission invites applications from public, private, academic, research and/or training centres, schools, SMEs or large corporates, EU-funded project consortia, public administrations, NGOs and citizen initiatives, who have either initiated or completed projects that foster the adoption of digital skills in one of the five awards categories to apply.
The five European Digital Skills Awards categories reflect the diversity of digital skills needs and initiatives shaping Europe’s digital future:
For more information about the initiative, the EC news article and the Digital Skills and Jobs Platform can be consulted. Applications can be submitted by completing this application form. Applications are open until 20 March.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
